Buy Stocks Easy | About Us

April 23, 2021

IMMP

Buy Immutep Limited Stock (symbol: IMMP) Easy Online

Company Name: Immutep Limited

Symbol: IMMP

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2012

IMMP Current Share Price

Today's IMMP ( Immutep Limited ) opening price: $1.6800

Yesterday's IMMP ( Immutep Limited ) closing price: $1.6400

Immutep Limited Stock ( symbol: IMMP ) Price Chart since IPO (2012):

12 Months Immutep Limited Stock ( symbol: IMMP ) Price Chart

Popular Questions about Immutep Limited Public Stock ( IMMP )

A: Immutep Limited stock symbol (also called stock or share ticker) is IMMP

A: Immutep Limited IPO (Initial Public Offering) took place on 2012

A: Immutep Limited's stock (IMMP symbol) price at ther IPO (initial Public Offering) was $1.6800

Q: Is IMMP stock worth buying at the moment?

A: The IMMP stock performance since 2019 are rather disappointing. If you had bought 1 share of Immutep Limited stock (symbol: IMMP) at the beginning of 2019, at the opening share price of $2.2300, you would be left with exactly $1.6800 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Immutep Limited Stock Easy Online

Immutep Limited Stock Ticker Price Chart since IPO:

Immutep Limited Stock Price Yesterday

Immutep Limited Stock Price – Last Week

Immutep Limited Stock Price – Last Month

Immutep Limited Stock Value Chart – 12 Months

Rate this post

Latest Stock News:

https://seekingalpha.com/article/4313526-near-term-upside-in-lagminus-3-immunotherapy-buy-immutep

Near-Term Upside In LAG-3 Immunotherapy - Buy Immutep

Near-Term Upside In LAG-3 Immunotherapy - Buy Immutep

http://www.globenewswire.com/news-release/2019/12/19/1962768/0/en/INSIGHT-004-Clinical-Trial-Update.html

INSIGHT-004 Clinical Trial Update

SYDNEY, Australia, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Immutep Limi...

http://www.globenewswire.com/news-release/2019/11/14/1947163/0/en/Immutep-Announces-European-Patent-Grant-for-LAG525-Antibody.html

Immutep Announces European Patent Grant for LAG525 Antibody

SYDNEY, Australia, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Immutep Limi...

http://www.globenewswire.com/news-release/2019/11/08/1944010/0/en/Immutep-Presents-Positive-Interim-Data-From-Phase-II-TACTI-002-Trial-at-SITC.html

Immutep Presents Positive Interim Data From Phase II TACTI-002 Trial at SITC

SYDNEY, Australia, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Immutep Limi...

http://www.globenewswire.com/news-release/2019/10/15/1929680/0/en/Immutep-Reports-Positive-Final-Efficacy-Data-from-TACTI-mel-Trial-in-Melanoma.html

Immutep Reports Positive Final Efficacy Data from TACTI-mel Trial in Melanoma

Key Trial Findings

http://www.globenewswire.com/news-release/2019/10/10/1927978/0/en/Immutep-Announces-Data-Presentations-at-Upcoming-Industry-Conferences.html

Immutep Announces Data Presentations at Upcoming Industry Conferences

SYDNEY, Australia, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Immutep Limi...

http://www.globenewswire.com/news-release/2019/10/10/1927980/0/en/Immutep-Receives-A-2-5-Million-R-D-Tax-Incentive-from-French-Government.html

Immutep Receives A$2.5 Million R&D Tax Incentive from French Government

SYDNEY, Australia, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Immutep Limi...

http://www.globenewswire.com/news-release/2019/09/26/1921219/0/en/Immutep-Announces-Expansion-of-Part-A-of-TACTI-002-Phase-II-Clinical-Trial-due-to-Positive-Interim-Data.html

Immutep Announces Expansion of Part A of TACTI-002 Phase II Clinical Trial due to Positive Interim Data

SYDNEY, Australia, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Immutep Lim...

http://www.globenewswire.com/news-release/2019/09/17/1916593/0/en/Immutep-Announces-Japanese-Patent-Grant-for-LAG525-Antibody.html

Immutep Announces Japanese Patent Grant for LAG525 Antibody

SYDNEY, Australia, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Immutep Lim...

http://www.globenewswire.com/news-release/2019/08/22/1905364/0/en/Immutep-Granted-European-Patent-for-Eftilagimod-Alpha-in-Cancer.html

Immutep Granted European Patent for Eftilagimod Alpha in Cancer

SYDNEY, Australia, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Immutep Limi...

All right reserved Buy Stocks Easy , 2019.